Capital Advantage »

Cytodin shares owned by Capital Advantage

Quarter-by-quarter ownership of Cytodin (CYDY) shares owned by Capital Advantage from 13F filings

Historical chart of Capital Advantage investment in Cytodin

Tip: Access up to 7 years of quarterly data

All positions including Cytodin held by Capital Advantage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytodin by Capital Advantage

Quarter filed Position value Share count Share price at filing
2023-06-30 $24k 91k 0.26
2021-12-31 $53k 91k 0.58
2021-09-30 $180k 91k 1.98
2021-06-30 $155k 91k 1.70

More positions owned by Capital Advantage

Vanguard Scottsdale Fds Int-term Corp (VCIT)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Ishares Tr Ultra Short Dur (ICSH)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard World Health Car Etf (VHT)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Select Sector Spdr Tr State Street Fin (XLF)
Spdr Series Trust State Street Spd (SPLG)
Vanguard World Industrial Etf (VIS)
Vanguard World Mega Cap Index (MGC)

View all positions for Capital Advantage

Top funds holding Cytodin

Nbc Securities
Diversified Trust Company
Williams Jones Wealth Management
Virtue Capital Management
RFP Financial Group
Next Capital Management
Horizon Financial Services
FineMark National Bank & Trust
Northstar Asset Management
Ancora Advisors
Caz Investments

View all funds holding Cytodin